Melanoma biology and new targeted therapy
Top Cited Papers
- 21 February 2007
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 445 (7130) , 851-857
- https://doi.org/10.1038/nature05661
Abstract
Melanoma is a cancer that arises from melanocytes, specialized pigmented cells that are found predominantly in the skin. The incidence of melanoma is rising steadily in western populations--the number of cases worldwide has doubled in the past 20 years. In its early stages malignant melanoma can be cured by surgical resection, but once it has progressed to the metastatic stage it is extremely difficult to treat and does not respond to current therapies. Recent discoveries in cell signalling have provided greater understanding of the biology that underlies melanoma, and these advances are being exploited to provide targeted drugs and new therapeutic approaches.Keywords
This publication has 85 references indexed in Scilit:
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisBritish Journal of Cancer, 2006
- Cellular senescence in naevi and immortalisation in melanoma: a role for p16?British Journal of Cancer, 2006
- Cutaneous Malignant MelanomaMayo Clinic Proceedings, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993